Page last updated: 2024-08-24

baicalin and oxidopamine

baicalin has been researched along with oxidopamine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fu, Y; Gao, J; Kang, C; Kang, M; Liu, X; Wang, L1
Chen, G; Kang, Z; Ma, J; Zhai, H; Zhang, H1

Other Studies

2 other study(ies) available for baicalin and oxidopamine

ArticleYear
Baicalin alleviates 6-hydroxydopamine-induced neurotoxicity in PC12 cells by down-regulation of microRNA-192-5p.
    Brain research, 2019, 04-01, Volume: 1708

    Topics: Animals; Apoptosis; Autophagy; Cell Survival; Flavonoids; MicroRNAs; Neurotoxicity Syndromes; Oxidopamine; Parkinson Disease; PC12 Cells; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-mdm2; Rats; Signal Transduction; Tumor Suppressor Protein p53

2019
Baicalin attenuated substantia nigra neuronal apoptosis in Parkinson's disease rats via the mTOR/AKT/GSK-3β pathway.
    Journal of integrative neuroscience, 2019, Dec-30, Volume: 18, Issue:4

    Topics: Animals; Apoptosis; Behavior, Animal; Disease Models, Animal; Female; Flavonoids; Glycogen Synthase Kinase 3 beta; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction; Substantia Nigra; TOR Serine-Threonine Kinases

2019